The effects of octreotide in dilated cardiomyopathy - An open-label trial in 12 patients


Creative Commons License

Eryol N. K. , Guven M. , Topsakal R. , Sungur M. , Ozdogru I., Inanc T., ...Daha Fazla

JAPANESE HEART JOURNAL, cilt.45, ss.613-621, 2004 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 45 Konu: 4
  • Basım Tarihi: 2004
  • Doi Numarası: 10.1536/jhj.45.613
  • Dergi Adı: JAPANESE HEART JOURNAL
  • Sayfa Sayıları: ss.613-621

Özet

Octreotide, a somatostatin analogue, has been found effective in the treatment of acromegalic cardiomyopathy. We investigated whether intermittent octreotide therapy had beneficial effects in patients with ischemic or idiopathic dilated cardiomyopathy, which are refractory to conventional therapy.